BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 25479461)

  • 21. The sensitivity of fecal calprotectin in predicting deep remission in ulcerative colitis.
    Carlsen K; Riis LB; Elsberg H; Maagaard L; Thorkilgaard T; Sørbye SW; Jakobsen C; Wewer V; Florholmen J; Goll R; Munkholm P
    Scand J Gastroenterol; 2018; 53(7):825-830. PubMed ID: 29968483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of clinical indexes in ulcerative colitis patients in regular follow-up visit: correlation with endoscopic 'mucosal healing' and implication for management. Preliminary results.
    Pagnini C; Menasci F; Festa S; Rizzatti G; Corleto VD; Delle Fave MM; D'Ambra G; Di Giulio E; Delle Fave G
    Eur Rev Med Pharmacol Sci; 2015 Oct; 19(19):3674-81. PubMed ID: 26502857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical relevance of endoscopic assessment of inflammation in ulcerative colitis: Can endoscopic evaluation predict outcomes?
    Mohammed N; Subramanian V
    World J Gastroenterol; 2016 Nov; 22(42):9324-9332. PubMed ID: 27895420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of mucosal healing (Mayo 0) on clinical relapse in patients with ulcerative colitis in clinical remission.
    Kim JH; Cheon JH; Park Y; Lee HJ; Park SJ; Kim TI; Kim WH
    Scand J Gastroenterol; 2016 Sep; 51(9):1069-74. PubMed ID: 26895215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of Histological and Endoscopic Remissions on Clinical Recurrence and Recurrence-free Time in Ulcerative Colitis.
    Ponte A; Pinho R; Fernandes S; Rodrigues A; Alberto L; Silva JC; Silva J; Rodrigues J; Sousa M; Silva AP; Proença L; Freitas T; Leite S; Carvalho J
    Inflamm Bowel Dis; 2017 Dec; 23(12):2238-2244. PubMed ID: 28991857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Definitions of response and remission for the Robarts Histopathology Index.
    Pai RK; Khanna R; D'Haens GR; Sandborn WJ; Jeyarajah J; Feagan BG; Vande Casteele N; Jairath V
    Gut; 2019 Nov; 68(11):2101-2102. PubMed ID: 30366909
    [No Abstract]   [Full Text] [Related]  

  • 27. Fecal Calprotectin Levels Predict Histological Healing in Ulcerative Colitis.
    Patel A; Panchal H; Dubinsky MC
    Inflamm Bowel Dis; 2017 Sep; 23(9):1600-1604. PubMed ID: 28590341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complete mucosal healing defined by endoscopic Mayo subscore still demonstrates abnormalities by novel high definition colonoscopy and refined histological gradings.
    Iacucci M; Fort Gasia M; Hassan C; Panaccione R; Kaplan GG; Ghosh S; Gui X
    Endoscopy; 2015 Aug; 47(8):726-34. PubMed ID: 25826276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Ulcerative Colitis Endoscopic Index of Severity More Accurately Reflects Clinical Outcomes and Long-term Prognosis than the Mayo Endoscopic Score.
    Ikeya K; Hanai H; Sugimoto K; Osawa S; Kawasaki S; Iida T; Maruyama Y; Watanabe F
    J Crohns Colitis; 2016 Mar; 10(3):286-95. PubMed ID: 26581895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Impact of Endoscopic Inflammation and Mucosal Healing on Health-related Quality of Life in Ulcerative Colitis Patients.
    Theede K; Kiszka-Kanowitz M; Nordgaard-Lassen I; Mertz Nielsen A
    J Crohns Colitis; 2015 Aug; 9(8):625-32. PubMed ID: 25956537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tacrolimus for remission induction in ulcerative colitis: Mayo endoscopic subscore 0 and 1 predict long-term prognosis.
    Ikeya K; Sugimoto K; Kawasaki S; Iida T; Maruyama Y; Watanabe F; Hanai H
    Dig Liver Dis; 2015 May; 47(5):365-71. PubMed ID: 25682993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized, double-blind, sham-controlled study of granulocyte/monocyte apheresis for active ulcerative colitis.
    Sands BE; Sandborn WJ; Feagan B; Löfberg R; Hibi T; Wang T; Gustofson LM; Wong CJ; Vandervoort MK; Hanauer S;
    Gastroenterology; 2008 Aug; 135(2):400-9. PubMed ID: 18602921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Agreement Between Rectosigmoidoscopy and Colonoscopy Analyses of Disease Activity and Healing in Patients With Ulcerative Colitis.
    Colombel JF; Ordás I; Ullman T; Rutgeerts P; Chai A; O'Byrne S; Lu TT; Panés J
    Gastroenterology; 2016 Feb; 150(2):389-95.e3. PubMed ID: 26526713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Ulcerative Colitis Endoscopic Index of Severity is Useful to Predict Medium- to Long-Term Prognosis in Ulcerative Colitis Patients with Clinical Remission.
    Arai M; Naganuma M; Sugimoto S; Kiyohara H; Ono K; Mori K; Saigusa K; Nanki K; Mutaguchi M; Mizuno S; Bessho R; Nakazato Y; Hosoe N; Matsuoka K; Inoue N; Ogata H; Iwao Y; Kanai T
    J Crohns Colitis; 2016 Nov; 10(11):1303-1309. PubMed ID: 27194529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical, endoscopic and histological correlation and measures of association in ulcerative colitis.
    Fluxá D; Simian D; Flores L; Ibáñez P; Lubascher J; Figueroa C; Kronberg U; Pizarro G; Castro M; Piottante A; Vial MT; Quera R
    J Dig Dis; 2017 Nov; 18(11):634-641. PubMed ID: 28949435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential utility of a new ulcerative colitis segmental endoscopic index combining disease severity and the extent of inflammation.
    Suzuki Y; Uchiyama K; Kato M; Matsuo K; Nakagawa T; Kishikawa H; Kimura N; Kasanuki J; Ino S
    J Clin Gastroenterol; 2015; 49(5):401-6. PubMed ID: 25127112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation of Fecal Markers with Magnifying Endoscopic Stratification in Patients with Ulcerative Colitis Who Are in Clinical Remission.
    Mine S; Takeshima F; Akazawa Y; Matsushima K; Minami H; Yamaguchi N; Ohnita K; Isomoto H; Nakao K
    Digestion; 2018; 97(1):82-89. PubMed ID: 29393146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usefulness of fecal calprotectin for the early prediction of short-term outcomes of remission-induction treatments in ulcerative colitis in comparison with two-item patient-reported outcome.
    Toyonaga T; Kobayashi T; Nakano M; Saito E; Umeda S; Okabayashi S; Ozaki R; Hibi T
    PLoS One; 2017; 12(9):e0185131. PubMed ID: 28934315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Faecal Lactoferrin, Calprotectin, PMN-elastase, CRP, and White Blood Cell Count as Indicators for Mucosal Healing and Clinical Course of Disease in Patients with Mild to Moderate Ulcerative Colitis: Post Hoc Analysis of a Prospective Clinical Trial.
    Langhorst J; Boone J; Lauche R; Rueffer A; Dobos G
    J Crohns Colitis; 2016 Jul; 10(7):786-94. PubMed ID: 26874351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Can endoscopy be avoided in the assessment of ulcerative colitis in clinical trials?
    Dhanda AD; Creed TJ; Greenwood R; Sands BE; Probert CS
    Inflamm Bowel Dis; 2012 Nov; 18(11):2056-62. PubMed ID: 22271464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.